Study of Gefapixant (MK-7264) in Acute Cough for Participants With Induced Viral Upper Respiratory Tract Infection (URTI) (MK-7264-013)
Clinical trial NCT03569033 · TERMINATED
Trial details
- NCT number
- NCT03569033
- Sponsor
- Merck Sharp & Dohme LLC
- Status
- TERMINATED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2018-07-04
- Primary completion
- 2018-10-31
- Enrollment
- 46
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.